Nektar(NKTR) - 2019 Q4 - Earnings Call Transcript

Nektar Therapeutics (NASDAQ:NKTR) Q4 2019 Results Conference Call February 27, 2020 5:00 PM ET CompanyParticipants Jennifer Ruddock - Senior Vice President, Strategy and Corporate Affairs Howard Robin - President and Chief Executive Officer Dr. Wei Lin - Senior Vice President and Head of Development Dr. Jonathan Zalevsky - Chief Research and Development Officer Gil Labrucherie - Chief Operating Officer and Chief Financial Officer Conference Call Participants Chris Shibutani - Cowen Alexander Duncan - Piper ...